Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 712

1.

Scleroderma Renal Crisis: Still a Lot To Do.

Codullo V, Montecucco C.

J Rheumatol. 2019 Jan;46(1):3-4. doi: 10.3899/jrheum.180594. No abstract available.

PMID:
30600234
2.

"Disease knowledge index" and perspectives on reproductive issues: A nationwide study on 398 women with autoimmune rheumatic diseases.

Andreoli L, Lazzaroni MG, Carini C, Dall'Ara F, Nalli C, Reggia R, Rodrigues M, Benigno C, Baldissera E, Bartoloni-Bocci E, Basta F, Bellisai F, Bortoluzzi A, Campochiaro C, Cantatore FP, Caporali R, Ceribelli A, Chighizola CB, Conigliaro P, Corrado A, Cutolo M, D'Angelo S, De Stefani E, Doria A, Favaro M, Fischetti C, Foti R, Gabrielli A, Generali E, Gerli R, Gerosa M, Larosa M, Maier A, Malavolta N, Meroni M, Meroni PL, Montecucco C, Mosca M, Padovan M, Paolazzi G, Pazzola G, Peccatori S, Perricone R, Pettiti G, Picerno V, Prevete I, Ramoni V, Romeo N, Ruffatti A, Salvarani C, Sebastiani GD, Selmi C, Serale F, Sinigaglia L, Tani C, Trevisani M, Vadacca M, Valentini E, Valesini G, Visalli E, Vivaldelli E, Zuliani L, Tincani A.

Joint Bone Spine. 2018 Dec 21. pii: S1297-319X(18)30257-4. doi: 10.1016/j.jbspin.2018.12.002. [Epub ahead of print]

PMID:
30579917
3.

The Clinical Value of Autoantibodies in Rheumatoid Arthritis.

Bugatti S, Manzo A, Montecucco C, Caporali R.

Front Med (Lausanne). 2018 Dec 3;5:339. doi: 10.3389/fmed.2018.00339. eCollection 2018. Review.

4.

Aging in Primary Systemic Vasculitis: Implications for Diagnosis, Clinical Manifestations, and Management.

Berti A, Caporali R, Montecucco C, Paolazzi G, Monti S.

Drugs Aging. 2019 Jan;36(1):53-63. doi: 10.1007/s40266-018-0617-4. Review.

PMID:
30484240
5.

Preliminary Validation of the Digital Ulcer Clinical Assessment Score in Systemic Sclerosis.

Bruni C, Ngcozana T, Braschi F, Pucci T, Piemonte G, Benelli L, Poli M, Suliman YA, Guiducci S, Bellando-Randone S, Balduzzi S, Grotts J, Denton CP, Rasero L, Montecucco C, Furst DE, Matucci-Cerinic M.

J Rheumatol. 2018 Nov 15. pii: jrheum.171486. doi: 10.3899/jrheum.171486. [Epub ahead of print]

PMID:
30442833
6.

Nailfold Capillaroscopy Characteristics of Antisynthetase Syndrome and Possible Clinical Associations: Results of a Multicenter International Study.

Sebastiani M, Triantafyllias K, Manfredi A, González-Gay MA, Palmou-Fontana N, Cassone G, Drott U, Delbrück C, Rojas-Serrano J, Bertolazzi C, Nuño L, Giannini M, Iannone F, Vicente EF, Castañeda S, Selva-O'Callaghan A, Araguas ET, Emmi G, Iuliano A, Bauhammer J, Miehle N, Parisi S, Cavagna L, Codullo V, Montecucco C, Lopez-Longo FJ, Martínez-Barrio J, Nieto-González JC, Vichi S, Confalonieri M, Tomietto P, Bergner R, Sulli A, Bonella F, Furini F, Scirè CA, Bortoluzzi A, Specker C, Barsotti S, Neri R, Mosca M, Caproni M, Weinmann-Menke J, Schwarting A, Smith V, Cutolo M; American and European Network of Antisynthetase Syndrome Collaborative Group.

J Rheumatol. 2018 Nov 15. pii: jrheum.180355. doi: 10.3899/jrheum.180355. [Epub ahead of print]

PMID:
30442823
7.

Patients', physicians', nurses', and pharmacists' preferences on the characteristics of biologic agents used in the treatment of rheumatic diseases.

Scalone L, Sarzi-Puttini P, Sinigaglia L, Montecucco C, Giacomelli R, Lapadula G, Olivieri I, Giardino AM, Cortesi PA, Mantovani LG, Mecchia M.

Patient Prefer Adherence. 2018 Oct 16;12:2153-2168. doi: 10.2147/PPA.S168458. eCollection 2018.

8.

Antiphospholipid syndrome: state of the art on clinical practice guidelines.

Limper M, Scirè CA, Talarico R, Amoura Z, Avcin T, Basile M, Burmester G, Carli L, Cervera R, Costedoat-Chalumeau N, Doria A, Dörner T, Fonseca JE, Galetti I, Hachulla E, Launay D, Lourenco F, Macieira C, Meroni P, Montecucco CM, Moraes-Fontes MF, Mouthon L, Nalli C, Ramoni V, Tektonidou M, van Laar JM, Bombardieri S, Schneider M, Smith V, Vieira A, Cutolo M, Mosca M, Tincani A.

RMD Open. 2018 Oct 18;4(Suppl 1):e000785. doi: 10.1136/rmdopen-2018-000785. eCollection 2018.

9.

Serum calprotectin as a marker of clinical and ultrasound-detected synovitis in early psoriatic and rheumatoid arthritis: results from a cross-sectional retrospective study.

Sakellariou G, Lombardi G, Vitolo B, Gomarasca M, Faraldi M, Caporali R, Banfi G, Montecucco C.

Clin Exp Rheumatol. 2018 Oct 8. [Epub ahead of print]

PMID:
30299248
10.

Dose adjustments and discontinuation in TNF inhibitors treated patients: when and how. A systematic review of literature.

Ruscitti P, Sinigaglia L, Cazzato M, Grembiale RD, Triolo G, Lubrano E, Montecucco C, Giacomelli R.

Rheumatology (Oxford). 2018 Oct 1;57(57 Suppl 7):vii23-vii31. doi: 10.1093/rheumatology/key132. Review.

PMID:
30289540
11.

20 years of experience with tumour necrosis factor inhibitors: what have we learned?

Caporali R, Crepaldi G, Codullo V, Benaglio F, Monti S, Todoerti M, Montecucco C.

Rheumatology (Oxford). 2018 Oct 1;57(57 Suppl 7):vii5-vii10. doi: 10.1093/rheumatology/key059. Review.

PMID:
30289535
12.

Histopathology of the synovial tissue: perspectives for biomarker development in chronic inflammatory arthritides.

Manzo A, Bugatti S, Caporali R, Montecucco C.

Reumatismo. 2018 Oct 3;70(3):121-132. doi: 10.4081/reumatismo.2018.1057.

13.

Primary resistance of human patients to botulinum neurotoxins A and B.

Pirazzini M, Carle S, Barth H, Rossetto O, Montecucco C.

Ann Clin Transl Neurol. 2018 Jul 17;5(8):971-975. doi: 10.1002/acn3.586. eCollection 2018 Aug.

14.

The role of extra-corporeal membrane oxygenation (ECMO) in the treatment of diffuse alveolar haemorrhage secondary to ANCA-associated vasculitis: report of two cases and review of the literature.

Delvino P, Monti S, Balduzzi S, Belliato M, Montecucco C, Caporali R.

Rheumatol Int. 2018 Aug 3. doi: 10.1007/s00296-018-4116-z. [Epub ahead of print] Review.

PMID:
30074077
15.

An Interview with Cesare Montecucco.

Montecucco C.

Toxins (Basel). 2018 Jul 24;10(8). pii: E307. doi: 10.3390/toxins10080307.

16.

Detection of Clostridium tetani Neurotoxins Inhibited In Vivo by Botulinum Antitoxin B: Potential for Misleading Mouse Test Results in Food Controls.

Bano L, Tonon E, Drigo I, Pirazzini M, Guolo A, Farina G, Agnoletti F, Montecucco C.

Toxins (Basel). 2018 Jun 19;10(6). pii: E248. doi: 10.3390/toxins10060248.

17.

Hydrogen peroxide is a neuronal alarmin that triggers specific RNAs, local translation of Annexin A2, and cytoskeletal remodeling in Schwann cells.

Negro S, Stazi M, Marchioretto M, Tebaldi T, Rodella U, Duregotti E, Gerke V, Quattrone A, Montecucco C, Rigoni M, Viero G.

RNA. 2018 Jul;24(7):915-925. doi: 10.1261/rna.064816.117. Epub 2018 Apr 11.

18.

Discovery of novel bacterial toxins by genomics and computational biology.

Doxey AC, Mansfield MJ, Montecucco C.

Toxicon. 2018 Jun 1;147:2-12. doi: 10.1016/j.toxicon.2018.02.002. Epub 2018 Feb 10. Review.

PMID:
29438679
19.

A Multicenter Retrospective Analysis Evaluating Performance of Synovial Biopsy Techniques in Patients With Inflammatory Arthritis: Arthroscopic Versus Ultrasound-Guided Versus Blind Needle Biopsy.

Humby F, Romão VC, Manzo A, Filer A, Bugatti S, Vieira-Sousa E, Kelly S, Wechalekar M, Ahmed M, Rocher V, Hands R, Montecucco C, Fonseca J, Pitzalis C.

Arthritis Rheumatol. 2018 May;70(5):702-710. doi: 10.1002/art.40433. Epub 2018 Apr 2.

PMID:
29409140
20.

High Conservation of Tetanus and Botulinum Neurotoxins Cleavage Sites on Human SNARE Proteins Suggests That These Pathogens Exerted Little or No Evolutionary Pressure on Humans.

Carle S, Pirazzini M, Rossetto O, Barth H, Montecucco C.

Toxins (Basel). 2017 Dec 19;9(12). pii: E404. doi: 10.3390/toxins9120404.

21.

Hsp90 and Thioredoxin-Thioredoxin Reductase enable the catalytic activity of Clostridial neurotoxins inside nerve terminals.

Pirazzini M, Azarnia Tehran D, Zanetti G, Rossetto O, Montecucco C.

Toxicon. 2018 Jun 1;147:32-37. doi: 10.1016/j.toxicon.2017.10.028. Epub 2017 Oct 28. Review.

PMID:
29111118
22.

TNF inhibitors in rheumatoid arthritis and spondyloarthritis: Are they the same?

Rubbert-Roth A, Atzeni F, Masala IF, Caporali R, Montecucco C, Sarzi-Puttini P.

Autoimmun Rev. 2018 Jan;17(1):24-28. doi: 10.1016/j.autrev.2017.11.005. Epub 2017 Nov 3. Review.

PMID:
29108829
23.

Undifferentiated connective tissue diseases and adverse pregnancy outcomes. An undervalued association?

Spinillo A, Beneventi F, Caporali R, Ramoni V, Montecucco C.

Am J Reprod Immunol. 2017 Dec;78(6). doi: 10.1111/aji.12762. Epub 2017 Sep 16. Review.

PMID:
28921728
24.

Prevalence of Ankylosing Spondylitis Disease Activity Score (ASDAS) inactive disease in a cohort of patients treated with TNF-alpha inhibitors.

Monti S, Todoerti M, Codullo V, Favalli EG, Biggioggero M, Becciolini A, Montecucco C, Caporali R.

Mod Rheumatol. 2018 May;28(3):542-549. doi: 10.1080/14397595.2017.1367076. Epub 2017 Sep 7.

PMID:
28880727
25.

Mapping and predicting mortality from systemic sclerosis.

Elhai M, Meune C, Boubaya M, Avouac J, Hachulla E, Balbir-Gurman A, Riemekasten G, Airò P, Joven B, Vettori S, Cozzi F, Ullman S, Czirják L, Tikly M, Müller-Ladner U, Caramaschi P, Distler O, Iannone F, Ananieva LP, Hesselstrand R, Becvar R, Gabrielli A, Damjanov N, Salvador MJ, Riccieri V, Mihai C, Szücs G, Walker UA, Hunzelmann N, Martinovic D, Smith V, Müller CS, Montecucco CM, Opris D, Ingegnoli F, Vlachoyiannopoulos PG, Stamenkovic B, Rosato E, Heitmann S, Distler JHW, Zenone T, Seidel M, Vacca A, Langhe E, Novak S, Cutolo M, Mouthon L, Henes J, Chizzolini C, Mühlen CAV, Solanki K, Rednic S, Stamp L, Anic B, Santamaria VO, De Santis M, Yavuz S, Sifuentes-Giraldo WA, Chatelus E, Stork J, Laar JV, Loyo E, García de la Peña Lefebvre P, Eyerich K, Cosentino V, Alegre-Sancho JJ, Kowal-Bielecka O, Rey G, Matucci-Cerinic M, Allanore Y; EUSTAR group.

Ann Rheum Dis. 2017 Nov;76(11):1897-1905. doi: 10.1136/annrheumdis-2017-211448. Epub 2017 Aug 23.

PMID:
28835464
26.

Identification and characterization of Clostridium botulinum group III field strains by matrix-assisted laser desorption-ionization time-of-flight mass spectrometry (MALDI-TOF MS).

Bano L, Drigo I, Tonon E, Pascoletti S, Puiatti C, Anniballi F, Auricchio B, Lista F, Montecucco C, Agnoletti F.

Anaerobe. 2017 Dec;48:126-134. doi: 10.1016/j.anaerobe.2017.08.004. Epub 2017 Aug 10.

PMID:
28802703
27.

Clinical spectrum of anti-Jo-1-associated disease.

Monti S, Montecucco C, Cavagna L.

Curr Opin Rheumatol. 2017 Nov;29(6):612-617. doi: 10.1097/BOR.0000000000000434. Review.

PMID:
28796005
28.

Timing of onset affects arthritis presentation pattern in antisyntethase syndrome.

González-Gay MA, Montecucco C, Selva-O'Callaghan A, Trallero-Araguas E, Molberg O, Andersson H, Rojas-Serrano J, Perez-Roman DI, Bauhammer J, Fiehn C, Neri R, Barsotti S, Lorenz HM, Doria A, Ghirardello A, Iannone F, Giannini M, Franceschini F, Cavazzana I, Triantafyllias K, Benucci M, Infantino M, Manfredi M, Conti F, Schwarting A, Sebastiani G, Iuliano A, Emmi G, Silvestri E, Govoni M, Scirè CA, Furini F, Lopez-Longo FJ, Martínez-Barrio J, Sebastiani M, Manfredi A, Bachiller-Corral J, Sifuentes Giraldo WA, Cimmino MA, Cosso C, Belotti Masserini A, Cagnotto G, Codullo V, Romano M, Paolazzi G, Pellerito R, Saketkoo LA, Ortego-Centeno N, Quartuccio L, Batticciotto A, Bartoloni Bocci E, Gerli R, Specker C, Bravi E, Selmi C, Parisi S, Salaffi F, Meloni F, Marchioni E, Pesci A, Dei G, Confalonieri M, Tomietto P, Nuno L, Bonella F, Pipitone N, Mera-Valera A, Perez-Gomez N, Gerzeli S, Lopez-Mejias R, Matos-Costa CJ, Pereira da Silva JA, Cifrian J, Alpini C, Olivieri I, Blázquez Cañamero MÁ, Rodriguez Cambrón AB, Castañeda S, Cavagna L; AENEAS (American and European NEtwork of Antisynthetase Syndrome) collaborative group.

Clin Exp Rheumatol. 2018 Jan-Feb;36(1):44-49. Epub 2017 Jul 26.

29.

Response to Interleukin-1 Inhibitors in 140 Italian Patients with Adult-Onset Still's Disease: A Multicentre Retrospective Observational Study.

Colafrancesco S, Priori R, Valesini G, Argolini L, Baldissera E, Bartoloni E, Cammelli D, Canestrari G, Cantarini L, Cavallaro E, Cavalli G, Cerrito L, Cipriani P, Dagna L, Marchi G, Vita S, Emmi G, Ferraccioli G, Frassi M, Galeazzi M, Gerli R, Giacomelli R, Gremese E, Iannone F, Lapadula G, Lopalco G, Manna R, Mathieu A, Montecucco C, Mosca M, Piazza I, Piga M, Pontikaki I, Romano M, Rossi S, Rossini M, Ruscitti P, Silvestri E, Stagnaro C, Talarico R, Tincani A, Viapiana O, Vitiello G, Fabris F, Bindoli S, Punzi L, Galozzi P, Sfriso P.

Front Pharmacol. 2017 Jun 13;8:369. doi: 10.3389/fphar.2017.00369. eCollection 2017.

30.

CXCL12α/SDF-1 from perisynaptic Schwann cells promotes regeneration of injured motor axon terminals.

Negro S, Lessi F, Duregotti E, Aretini P, La Ferla M, Franceschi S, Menicagli M, Bergamin E, Radice E, Thelen M, Megighian A, Pirazzini M, Mazzanti CM, Rigoni M, Montecucco C.

EMBO Mol Med. 2017 Aug;9(8):1000-1010. doi: 10.15252/emmm.201607257.

31.

Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology.

Pirazzini M, Rossetto O, Eleopra R, Montecucco C.

Pharmacol Rev. 2017 Apr;69(2):200-235. doi: 10.1124/pr.116.012658. Review.

32.

Animal models for studying motor axon terminal paralysis and recovery.

Rigoni M, Montecucco C.

J Neurochem. 2017 Aug;142 Suppl 2:122-129. doi: 10.1111/jnc.13956. Epub 2017 Mar 21. Review.

33.

Electrophysiological Characterization of the Antarease Metalloprotease from Tityus serrulatus Venom.

Zornetta I, Scorzeto M, Mendes Dos Reis PV, De Lima ME, Montecucco C, Megighian A, Rossetto O.

Toxins (Basel). 2017 Feb 27;9(3). pii: E81. doi: 10.3390/toxins9030081.

34.

Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective study.

Bartoloni E, Gonzalez-Gay MA, Scirè C, Castaneda S, Gerli R, Lopez-Longo FJ, Martinez-Barrio J, Govoni M, Furini F, Pina T, Iannone F, Giannini M, Nuño L, Quartuccio L, Ortego-Centeno N, Alunno A, Specker C, Montecucco C, Triantafyllias K, Balduzzi S, Sifuentes-Giraldo WA, Paolazzi G, Bravi E, Schwarting A, Pellerito R, Russo A, Selmi C, Saketkoo LA, Fusaro E, Parisi S, Pipitone N, Franceschini F, Cavazzana I, Neri R, Barsotti S, Codullo V, Cavagna L.

Autoimmun Rev. 2017 Mar;16(3):253-257. doi: 10.1016/j.autrev.2017.01.008. Epub 2017 Jan 29. Review.

PMID:
28147261
35.

Schwann cells are activated by ATP released from neurons in an in vitro cellular model of Miller Fisher syndrome.

Rodella U, Negro S, Scorzeto M, Bergamin E, Jalink K, Montecucco C, Yuki N, Rigoni M.

Dis Model Mech. 2017 May 1;10(5):597-603. doi: 10.1242/dmm.027870. Epub 2017 Jan 6.

36.

B cell autoimmunity and bone damage in rheumatoid arthritis.

Bugatti S, Bogliolo L, Montecucco C, Manzo A.

Reumatismo. 2016 Dec 16;68(3):117-125. doi: 10.4081/reumatismo.2016.914. Review.

37.

In early inflammatory polyarthritis more intensive management according to the 2010 ACR/EULAR criteria leads to higher rates of clinical remission: comparison of two cohorts treated according to different treat-to-target protocols.

Balduzzi S, Scirè CA, Sakellariou G, Benaglio F, Bugatti S, Montecucco C, Caporali R.

Clin Exp Rheumatol. 2017 May-Jun;35(3):401-405. Epub 2016 Dec 13.

PMID:
27974097
38.

Power Doppler ultrasonographic assessment of the joint-draining lymph node complex in rheumatoid arthritis: a prospective, proof-of-concept study on treatment with tumor necrosis factor inhibitors.

Manzo A, Benaglio F, Vitolo B, Bortolotto C, Zibera F, Todoerti M, Alpini C, Bugatti S, Caporali R, Calliada F, Montecucco C.

Arthritis Res Ther. 2016 Oct 22;18(1):242.

39.

The impact of unrecognized autoimmune rheumatic diseases on the incidence of preeclampsia and fetal growth restriction: a longitudinal cohort study.

Spinillo A, Beneventi F, Locatelli E, Ramoni V, Caporali R, Alpini C, Albonico G, Cavagnoli C, Montecucco C.

BMC Pregnancy Childbirth. 2016 Oct 18;16(1):313.

40.

An animal model of Miller Fisher syndrome: Mitochondrial hydrogen peroxide is produced by the autoimmune attack of nerve terminals and activates Schwann cells.

Rodella U, Scorzeto M, Duregotti E, Negro S, Dickinson BC, Chang CJ, Yuki N, Rigoni M, Montecucco C.

Neurobiol Dis. 2016 Dec;96:95-104. doi: 10.1016/j.nbd.2016.09.005. Epub 2016 Sep 3.

41.
42.

Undiagnosed connective tissue diseases: High prevalence in pulmonary arterial hypertension patients.

Cavagna L, Codullo V, Ghio S, Scirè CA, Guzzafame E, Scelsi L, Rossi S, Montecucco C, Caporali R.

Medicine (Baltimore). 2016 Sep;95(39):e4827. doi: 10.1097/MD.0000000000004827.

43.

Erratum to "Inhibition of botulinum neurotoxins interchain disulfide bond reduction prevents the peripheral neuroparalysis of botulism" [Biochem. Pharmacol. 98 (2015) 522-530].

Zanetti G, Azarnia Tehran D, Pirazzini M, Binz T, Shone CC, Fillo S, Lista F, Rossetto O, Montecucco C.

Biochem Pharmacol. 2016 Sep 1;115:152. doi: 10.1016/j.bcp.2016.07.006. Epub 2016 Jul 12. No abstract available.

PMID:
27498956
44.

The first non Clostridial botulinum-like toxin cleaves VAMP within the juxtamembrane domain.

Zornetta I, Azarnia Tehran D, Arrigoni G, Anniballi F, Bano L, Leka O, Zanotti G, Binz T, Montecucco C.

Sci Rep. 2016 Jul 22;6:30257. doi: 10.1038/srep30257.

45.

Semicarbazone EGA Inhibits Uptake of Diphtheria Toxin into Human Cells and Protects Cells from Intoxication.

Schnell L, Mittler AK, Mattarei A, Azarnia Tehran D, Montecucco C, Barth H.

Toxins (Basel). 2016 Jul 15;8(7). pii: E221. doi: 10.3390/toxins8070221.

46.

Hsp90 is involved in the entry of clostridial neurotoxins into the cytosol of nerve terminals.

Azarnia Tehran D, Pirazzini M, Leka O, Mattarei A, Lista F, Binz T, Rossetto O, Montecucco C.

Cell Microbiol. 2017 Feb;19(2). doi: 10.1111/cmi.12647. Epub 2016 Aug 4.

PMID:
27404998
47.

Botulinum neurotoxin A1 likes it double sweet.

Montecucco C, Zanotti G.

Nat Struct Mol Biol. 2016 Jul 6;23(7):619-21. doi: 10.1038/nsmb.3253. No abstract available.

PMID:
27384187
48.

Effects of type II collagen epitope carbamylation and citrullination in human leucocyte antigen (HLA)-DR4(+) monozygotic twins discordant for rheumatoid arthritis.

De Santis M, Ceribelli A, Cavaciocchi F, Generali E, Massarotti M, Isailovic N, Crotti C, Scherer HU, Montecucco C, Selmi C.

Clin Exp Immunol. 2016 Sep;185(3):309-19. doi: 10.1111/cei.12825. Epub 2016 Jul 25.

49.

ATP Released by Injured Neurons Activates Schwann Cells.

Negro S, Bergamin E, Rodella U, Duregotti E, Scorzeto M, Jalink K, Montecucco C, Rigoni M.

Front Cell Neurosci. 2016 May 23;10:134. doi: 10.3389/fncel.2016.00134. eCollection 2016.

50.

Adult-onset Still's disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients.

Sfriso P, Priori R, Valesini G, Rossi S, Montecucco CM, D'Ascanio A, Carli L, Bombardieri S, LaSelva G, Iannone F, Lapadula G, Alivernini S, Ferraccioli G, Colaci M, Ferri C, Iacono D, Valentini G, Costa L, Scarpa R, LoMonaco A, Bagnari V, Govoni M, Piazza I, Adami S, Ciccia F, Triolo G, Alessandri E, Cutolo M, Cantarini L, Galeazzi M, Ruscitti P, Giacomelli R, Caso F, Galozzi P, Punzi L.

Clin Rheumatol. 2016 Jul;35(7):1683-9. doi: 10.1007/s10067-016-3308-8. Epub 2016 May 20.

PMID:
27207567

Supplemental Content

Loading ...
Support Center